Prostate Cancer Specification
0.1.0 - ci-build
Prostate Cancer Specification - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Document Subject
Hans Mueller Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)
Document Content
Erhöhter PSA-Wert (8,5 ng/ml). V.a. Prostatakarzinom. Bitte histologische Abklärung.
Makroskopische Messungen für alle 12 Prostatastanzen: Längen 1,3–1,9 cm, je 1 Zylinder pro Specimen. Stanzen 01–06 aus rechter Prostataregion (lateral basal/mid/apikal, medial basal/mid/apikal), Stanzen 07–12 aus linker Prostataregion (lateral basal/mid/apikal, medial basal/mid/apikal).
| Stanze | Lokalisation | Stanzenlänge (cm) | Zylinderanzahl im Gefäß |
|---|---|---|---|
| 01 | Rechts lateral basal | 1.8 | 1 |
| 02 | Rechts lateral mid | 1.6 | 1 |
| 03 | Rechts lateral apikal | 1.5 | 1 |
| 04 | Rechts medial basal | 1.9 | 1 |
| 05 | Rechts medial mid | 1.4 | 1 |
| 06 | Rechts medial apikal | 1.7 | 1 |
| 07 | Links lateral basal | 1.6 | 1 |
| 08 | Links lateral mid | 1.5 | 1 |
| 09 | Links lateral apikal | 1.8 | 1 |
| 10 | Links medial basal | 1.3 | 1 |
| 11 | Links medial mid | 1.7 | 1 |
| 12 | Links medial apikal | 1.4 | 1 |
Adenokarzinom in 7 von 12 Stanzen nachgewiesen (01, 02, 04, 06, 07, 09, 11). Gleason-Scores: Stanze 01 (3+4=7), Stanze 02 (4+3=7), Stanze 04 (4+4=8), Stanze 06 (3+3=6), Stanze 07 (4+5=9), Stanze 09 (3+4=7), Stanze 11 (3+4=7). Höchster Gleason-Score 4+5=9, ISUP-Gradgruppe 5. Benigne Befunde in Stanzen 03, 05, 08, 10, 12.
| Stanze | Befund | Gleason-Score | Tumoranteil |
|---|---|---|---|
| 01 | Adenokarzinom | 3+4=7 | 40% |
| 02 | Adenokarzinom | 4+3=7 | 60% |
| 03 | Benigne | - | - |
| 04 | Adenokarzinom | 4+4=8 | 80% |
| 05 | Benigne | - | - |
| 06 | Adenokarzinom | 3+3=6 | 20% |
| 07 | Adenokarzinom | 4+5=9 | 95% |
| 08 | Benigne | - | - |
| 09 | Adenokarzinom | 3+4=7 | 35% |
| 10 | Benigne | - | - |
| 11 | Adenokarzinom | 3+4=7 | 25% |
| 12 | Benigne | - | - |
7 von 12 Stanzen tumorbefallen (4 rechts: 01, 02, 04, 06; 3 links: 07, 09, 11). Prozentualer Tumoranteil 51%, Tumorlänge gesamt 52,7 mm. Perineurale Infiltration und Infiltration des periprostatischen Fettgewebes apikal nachgewiesen. Samenblaseninfiltration, lymphovaskuläre Invasion, intraduktales Karzinom, ASAP, High-grade-PIN und granulomatöse Prostatitis nicht nachgewiesen.
| Histologischer Typ | Azinäres Adenokarzinom (8140/3) |
| Gleason-Score | 4+5=9 (höchster Score) |
| ISUP-Gradgruppe | 5 (WHO 2016) |
| Positive Stanzen | 7 von 12 (4 rechts, 3 links) |
| Tumoranteil gesamt | 51% |
| Tumorlänge gesamt | 52,7 mm |
| Anteil Gleason 4/5 | 77% |
| Perineurale Infiltration | Nachgewiesen |
| Periprostatische Fettinvasion | Nachgewiesen (apikal) |
| Samenblaseninfiltration | Nicht nachgewiesen |
| Lymphovaskuläre Invasion | Nicht nachgewiesen |
| Intraduktales Karzinom | Nicht nachgewiesen |
| ASAP | Nicht nachgewiesen |
| High-grade-PIN | Nicht nachgewiesen |
Diagnose: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3)
Entry 2 - fullUrl = http://prostatecancerspec.org/Patient/Patient1
Resource Patient:
Hans Mueller Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)
Entry 3 - fullUrl = http://prostatecancerspec.org/Organization/PathologyLabOrganization
Resource Organization:
identifier:
http://example.hospital.de/organization-ids/ORG-PATH-001name: Pathologielabor
Entry 4 - fullUrl = http://prostatecancerspec.org/DiagnosticReport/CoreNeedleBiopsyReport
Resource DiagnosticReport:
Profile: MII PR Patho Report version: 2026.0.0
Pathology Synoptic report (Surgical Pathology)
Subject Hans Mueller Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001) Relevant Time 2024-01-20 15:00:00+0100 Reported 2024-01-20 15:30:00+0100 Performer Practitioner Maria Schneider Identifier Accession ID/E_24_001 Report Details
Code Value Flags Relevant Time Pathology report gross observation Narrative (Prostate) Makroskopische Messungen aller 12 Prostatastanzen Final 2024-01-15 14:00:00+0100 Pathology report microscopic observation Narrative Other stain (Prostate) Mikroskopische Befunde aller 12 Prostatastanzen Final 2024-01-17 10:00:00+0100 Pathology report final diagnosis Narrative Final 2023-03-15 Adenokarzinom der Prostata, Gleason-Score 7a (3+4) in 7 von 12 Stanzen, mit perineuralem Befall.
Entry 5 - fullUrl = http://prostatecancerspec.org/Observation/CoreNeedleBiopsyDiagnosticConclusionGrouper
Resource Observation:
Profile: MII PR Patho Diagnostic Conclusion Grouper version: 2026.0.0
basedOn: ServiceRequest Prostate Pathology biopsy report
status: Final
category: Laboratory
code: Pathology report final diagnosis Narrative
subject: Hans Mueller Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)
effective: 2023-03-15
performer: Practitioner Maria Schneider
hasMember:
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation World Health Organization tumor classification (observable entity)
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Gleason score in Specimen Qualitative
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Grade Cancer
- Observation Tissue cores.positive.carcinoma in Tissue core
- Observation Tissue cores.positive.carcinoma in Tissue core
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Tissue cores.positive.carcinoma in Tissue core
- Observation Total linear mm of carcinoma
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols
- Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Extraprostatic extension site [Anatomy] of Prostate tumor
- Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)
- Observation Atypical small acinar proliferation of prostate (disorder)
- Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
- Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy
derivedFrom:
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)
- Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)
- Observation Total linear mm of carcinoma
- Observation Total linear mm of carcinoma
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
Entry 6 - fullUrl = http://prostatecancerspec.org/Observation/CoreNeedleBiopsyMacroscopicGrouper
Resource Observation:
Profile: MII PR Patho Macroscopic Grouper version: 2026.0.0
status: Final
category: Laboratory
code: Pathology report gross observation Narrative
subject: Hans Mueller Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)
effective: 2024-01-15 14:00:00+0100
performer: Practitioner Maria Schneider
value: Makroskopische Messungen aller 12 Prostatastanzen
bodySite: Prostate
derivedFrom:
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Length of tissue core(s)
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Total number of cores in Tissue core
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
- Observation Anatomic part Laterality
Entry 7 - fullUrl = http://prostatecancerspec.org/Observation/CoreNeedleBiopsyMicroscopicGrouper
Resource Observation:
Profile: MII PR Patho Microscopic Grouper version: 2026.0.0
status: Final
category: Laboratory
code: Pathology report microscopic observation Narrative Other stain
subject: Hans Mueller Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)
effective: 2024-01-17 10:00:00+0100
performer: Practitioner Maria Schneider
value: Mikroskopische Befunde aller 12 Prostatastanzen
bodySite: Prostate
derivedFrom:
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)
- Observation Total linear mm of carcinoma
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols
- Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)
- Observation Atypical small acinar proliferation of prostate (disorder)
- Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
- Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)
- Observation Total linear mm of carcinoma
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols
- Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)
- Observation Atypical small acinar proliferation of prostate (disorder)
- Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
- Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)
- Observation Total linear mm of carcinoma
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols
- Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)
- Observation Atypical small acinar proliferation of prostate (disorder)
- Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
- Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)
- Observation Total linear mm of carcinoma
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols
- Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)
- Observation Atypical small acinar proliferation of prostate (disorder)
- Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
- Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)
- Observation Total linear mm of carcinoma
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols
- Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)
- Observation Atypical small acinar proliferation of prostate (disorder)
- Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
- Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)
- Observation Total linear mm of carcinoma
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols
- Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)
- Observation Atypical small acinar proliferation of prostate (disorder)
- Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
- Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
- Observation Gleason pattern.primary in Prostate tumor
- Observation Gleason pattern.secondary in Prostate tumor
- Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
- Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)
- Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)
- Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)
- Observation Total linear mm of carcinoma
- Observation Perineural invasion [Presence] in Cancer specimen
- Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols
- Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols
- Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)
- Observation Atypical small acinar proliferation of prostate (disorder)
- Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
- Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy
- Observation Histology and Behavior ICD-O-3 Cancer
- Observation Histology type in Cancer specimen Narrative
Entry 8 - fullUrl = http://prostatecancerspec.org/Encounter/CoreNeedleBiopsyEncounter
Resource Encounter:
identifier:
http://example.hospital.de/encounters/E_24_001status: completed
class: IMB
subject: Hans Mueller Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)
Entry 9 - fullUrl = http://prostatecancerspec.org/ServiceRequest/CoreNeedleBiopsyReportRequest
Resource ServiceRequest:
Profile: MII PR Patho Service Request version: 2026.0.0
identifier: Placer Identifier/PATH-RPT-2024-001
status: Completed
intent: Order
category: Pathology consultation, comprehensive, records and specimen with report (procedure)
code: No display for ServiceRequest.code (concept: Prostate Pathology biopsy report)
subject: Hans Mueller Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)
requester: Practitioner Andreas Weber
performer: Practitioner Maria Schneider
supportingInfo:
- No display for ServiceRequest.supportingInfo (reference: ->Observation Prostate specific Ag [Mass/volume] in Serum or Plasma)
- No display for ServiceRequest.supportingInfo (reference: ->Condition Bösartige Neubildung der Prostata)
specimen:
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample
- Specimen: extension = ; identifier = Placer Identifier,Filler Identifier; accessionIdentifier = https://pathologie.example-hospital.de/fhir/fn/befundbericht#E_24_001; status = available; type = Prostate tru-cut biopsy sample